Differential Expression of Apoptotic and Low-Grade Inflammatory Markers in Alzheimer Disease Compared to Diabetes Mellitus Type 1 and 2 | Zendy

Krystallenia Alexandraki | Zendy; Nikolaos V. Apostolopoulos | Zendy; Christos Adamopoulos | Zendy; Evangelia Stamouli | Zendy; Georgia Dalagiorgou | Zendy; Theo Papaioannou | Zendy; Antonios Analitis | Zendy; Marianna Karamanou | Zendy; Konstantinos Makrilakis | Zendy; Antonios Politis | Zendy; Christina Piperi | Zendy

Open Access

Differential Expression of Apoptotic and Low-Grade Inflammatory Markers in Alzheimer Disease Compared to Diabetes Mellitus Type 1 and 2

Author(s) -

Krystallenia Alexandraki,

Nikolaos V. Apostolopoulos,

Christos Adamopoulos,

Evangelia Stamouli,

Georgia Dalagiorgou,

Theo Papaioannou,

Antonios Analitis,

Marianna Karamanou,

Konstantinos Makrilakis,

Antonios Politis,

Christina Piperi

Publication year - 2018

Publication title -

the journal of applied laboratory medicine

Language(s) - English

Resource type - Journals

eISSN - 2576-9456

pISSN - 2475-7241

DOI - 10.1373/jalm.2018.027623

Subject(s) - type 2 diabetes mellitus , diabetes mellitus , apoptosis , disease , medicine , alzheimer's disease , inflammation , immunology , oncology , biology , endocrinology , genetics

Neuroinflammation, impaired brain insulin signaling, and neuronal apoptosis may be interrelated in the pathophysiology of people with Alzheimer disease (AD) and diabetes, either type 1 or 2 diabetes (T1D or T2D, respectively).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research